R&D Systems™ Recombinant Human IL-15R alpha Fc Chimera Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human IL-15R alpha Fc Chimera Protein is derived from Sf 21 (baculovirus). The Recombinant Human IL-15R alpha Fc Chimera Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 3601
• Molecular Weight (g/mol): 42.6 kDa (monomer)
• Name: IL-15R alpha
• Quantity: 100 μg
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived human IL-15 R alpha protein, (N-terminus) Human IL-15 R alpha (Ile31-Thr172) Accession &Num; EAW86418 IEGRDMD Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Structural Form: Disulfide-linked homodimer
• Endotoxin Concentration: <0.1 EU per 1μg of the protein by the LAL method.
• Gene Alias: CD215, CD215 antigen, IL15 R alpha, IL-15 R alpha, IL-15 receptor subunit alpha, IL15RA, IL-15RA, IL-15R-alpha, interleukin 15 receptor, alpha, interleukin-15 receptor subunit alpha, MGC104179
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.